Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Heart Failure
100%
Acute Hospital
12%
All-cause Mortality
12%
ATHENA
100%
B-type Natriuretic Peptide
12%
Bad Outcomes
12%
Clinical Congestion
12%
Congestion
25%
Diuretic Resistance
12%
Dyspnea
12%
Ejection Fraction
12%
Estimated Glomerular Filtration Rate
12%
Heart Failure Hospitalization
12%
High Dose
75%
Hispanic Americans
12%
Hospitalization Rate
12%
Hyperkalemia
12%
Left Ventricular Ejection Fraction
12%
Mineralocorticoid Receptor Antagonists
12%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
62%
Net Weight
12%
Neurohormonal Activation
12%
No Significant Difference
12%
Output Weights
12%
Placebo
25%
Race-ethnicity
12%
Randomized Clinical Trial
100%
Renal Function
12%
Serum Potassium
12%
Spironolactone
100%
Urine Output
12%
Usual Care
75%
Weight Change
12%
Well Tolerated
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
100%
All Cause Mortality
12%
Brain Natriuretic Peptide
75%
Congestive Heart Failure
12%
Diuretics
12%
Dyspnea
12%
Hyperkalemia
12%
Isotopes of Potassium
12%
Low Drug Dose
25%
Mineralocorticoid Antagonist
12%
Placebo
25%
Potassium
12%
Randomized Clinical Trial
100%
Spironolactone
100%